Announcing a new article publication for Cardiovascular Innovations and Applications journal. Radiation-induced cardiomyopathy has become a significant clinical challenge with the increased use of ...
The approval is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most ...
The European Commission has granted marketing authorization in the European Union (EU) for acoramidis, under the brand name ...
New real-world data suggest that two out of every five patients with transthyretin amyloid cardiomyopathy treated with ...
India's first heart failure registry reveals younger patients, high mortality rates, and varying causes of heart failure.
Pharma announced the European Commission has granted marketing authorization in the European Union for acoramidis, under the ...
Palo Alto, California Thursday, February 13, 2025, 12:00 Hrs [IST] ...
RIC involves a complex interplay of molecular and cellular processes that alter cardiac tissue and ultimately lead to restrictive cardiomyopathy. Ionizing radiation, a critical element in cancer ...
This group of pathological conditions includes dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy ... diagnosis and treatment. The authors also discuss permissive ...
Ashley Brooks, a two-time heart transplant recipient, is now a heart disease awareness advocate, encouraging others to wear red on February 7 to save lives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback